M. Sàbat

发表

Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients.

E. Ricart, J. Dedeu, J. Sola-Vera, 2000, Journal of hepatology.

RAID Prediction: Pilot Study of Fecal Microbial Signature With Capacity to Predict Response to Anti-TNF Treatment.

J. Garcia-Gil, D. Busquets, X. Aldeguer, 2021, Inflammatory bowel diseases.

Epidemiological approximation of the enteric manifestation and possible fecal-oral transmission in COVID-19: a preliminary systematic review.

C. Soler, R. Solano, M. Sàbat, 2020, European journal of gastroenterology & hepatology.

High prevalence of SARS-CoV-2 infection in patients scheduled for digestive endoscopy after the peak of the first wave of the pandemic

Rosa Durández, R. Solano, M. Sàbat, 2021, Gastroenterología y Hepatología (English Edition).

A novel distinctive form of identification for differential diagnosis of irritable bowel syndrome, inflammatory bowel disease, and healthy controls

I. Marín, J. Serra, Javier Santos, 2020 .

Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding.

J. Boadas, J. Miñana, G. Soriano, 2001, Gastroenterology.

Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study

J. Gisbert, F. Rodríguez‐Artalejo, X. Calvet, 2021, Journal of clinical medicine.

Effect of Subcutaneous Administration of Octreotide on Endogenous Vasoactive Systems and Renal Function in Cirrhotic Patients with Ascites

O. Bulbena, J. Roselló, E. Ricart, 1998, Digestive Diseases and Sciences.

Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin

M. Andreu, G. Soriano, C. Guarner, 1997, Hepatology.

Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels.

M. Andreu, R. Solá, G. Soriano, 1999, Gastroenterology.

Early microbiologic diagnosis of spontaneous bacterial peritonitis with BacT/ALERT.

P. Coll, G. Prats, G. Soriano, 1997, Journal of hepatology.

Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: A prospective randomized trial

J. Boadas, X. Cussó, X. Torras, 1999, Hepatology.

Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding

G. Soriano, C. Guarner, C. Villanueva, 1998, American Journal of Gastroenterology.

Somatostatin alone or combined with emergency sclerotherapy for acute variceal bleeding

G. Soriano, C. Villanueva, J. Balanzó, 1997 .

Anti-tumour Necrosis Factor Treatment with Adalimumab Induces Changes in the Microbiota of Crohn's Disease.

J. Garcia-Gil, M. López-Siles, M. Martinez-Medina, 2015, Journal of Crohn's & colitis.

Injection therapy alone or with endoscopic hemoclip for bleeding peptic ulcer, preliminary results of a randomized trial

X. Torras, G. Soriano, C. Villanueva, 1996 .

Infections caused by escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients

M. Andreu, R. Solá, G. Prats, 1999, Hepatology.

Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology

R. Peracaula, R. de Llorens, M. Sáez, 2016, PloS one.

Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.

G. Soriano, C. Guarner, C. Villanueva, 1998 .

High prevalence of SARS-CoV-2 infection in patients scheduled for digestive endoscopy after the peak of the first wave of the pandemic.

Rosa Durández, R. Solano, M. Sàbat, 2021, Gastroenterologia y hepatologia.

Final results of a prospective and randomized trial evaluating endoscopic hemoclip for bleeding peptic ulcer

X. Cussó, X. Torras, G. Soriano, 1998 .

In vitro Prebiotic Effect of Bread-Making Process in Inflammatory Bowel Disease Microbiome

D. Busquets, X. Aldeguer, M. Cambra, 2021, Frontiers in Microbiology.

Chracteristics of the infections caused by Escherichia coli resistant, to norfloxacin in hospitalized cirrhotic patients

M. Andreu, R. Solá, G. Prats, 1995 .

Anti-tumour Necrosis Factor Treatment with Adalimumab Induces Changes in the Microbiota of Crohn's Disease.

J. Garcia-Gil, M. López-Siles, M. Martinez-Medina, 2015, Journal of Crohn's & colitis.